MADRMaster of Arts in Dispute Resolution (degree program)
MADRMaximum Allowable Data Rate
References in periodicals archive ?
The MADR approach is being utilized by Predictive in the development of its CertNDx line of cancer assays, and is an extension of Predictive's Clinical Intervention Determining Diagnostic (CIDD[TM]) approach.
The MADR research, which combines protein and DNA biomarkers to identify with high certainty a group of bladder cancer patients who are disease free and could be excluded from undergoing invasive procedures, was conducted under collaboration agreements with Lahey Clinic Medical Center and Mayo Clinic.
Predictive's proprietary MADR method is an extension of its Clinical Intervention Determining Diagnostic approach - termed CIDD - to the non-invasive management of bladder and other cancers.